Sertraline HCl Market Size Was Valued at USD 5.16 Billion in 2023, and is Projected to Reach USD 7.0 Billion by 2032, Growing at a CAGR of 3.46% From 2024-2032.
Sertraline hydrochloride (HCl) a commonly prescribed antidepressant in the SSRIs family of drugs. This drug is usually used in various mental and psychiatric disorders including major depressive disorder, panic disorder, Obsessive-compulsive disorder, Post-traumatic stress disorder, social anxiety disorder and premenstrual dysphoric disorder. The market of Sertraline HCl includes the manufacturing, supply and trading of this chemical compound and its products such as tablets and oral solution.